REED ELIZABETH E bought TVTX
September 15, 2026 · Form 4 insider transaction
REED ELIZABETH E bought 37,500 shares of Travere Therapeutics, Inc. at $15.46 per share, a transaction worth $579.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
37,500
Price
$15.46
Total value
$579.8K
InsiderREED ELIZABETH E
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 15, 2026
Filing dateSeptember 17, 2026
Shares owned after142,889
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes 178 shares acquired under the Issuer's 2017 Employee Stock Purchase Plan on May 29, 2026.